Top Banner
44

Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Dec 15, 2015

Download

Documents

Dillan Edlin
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.
Page 2: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Kathryn L. Burgio, PhDKathryn L. Burgio, PhDAssociate Director for GRECC ResearchAssociate Director for GRECC Research

&&

Patricia S. Goode, MDPatricia S. Goode, MDAssociate Director for GRECC Clinical ProgramsAssociate Director for GRECC Clinical Programs

Birmingham/Atlanta Geriatric Research EducationBirmingham/Atlanta Geriatric Research Education and Clinical Center – July 27, 2006and Clinical Center – July 27, 2006

Assessment and Management of Assessment and Management of Urinary Incontinence in the ClinicUrinary Incontinence in the Clinic

Page 3: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

05

10152025303540

20-24

25-29

30-34

35-39

40-44

45-49

50-54

55-59

60-64

65-69

70-74

75-79

80-84

85+

Age

Pre

vale

nce

(%

)

Severe Moderate

Slight Unknown

Hannestad et al., 2000

Prevalence of Prevalence of IncontinenceIncontinence

Severity

Page 4: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

UI - Treatment Seeking UI - Treatment Seeking

Reported toProviderNot Reported

1,104 Community Dwelling Older Adults with Urinary Incontinence on interview

Burgio, et al: JAGS 42: 208, 1994Burgio, et al: JAGS 42: 208, 1994

38%38%62%62%

Page 5: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Reasons for Not Reporting Incontinence to Provider

Not aware that can be treatedNormal part of agingPersonal problem (not medical)EmbarrassedFear of nursing home placementAfraid treatment requires surgery

Page 6: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Include Incontinence in the Review of Systems for all geriatric patients.

Page 7: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Patient Case

75 year old man Goes to the bathroom every 1-2 hours

daytime and 3 times at night. About once a week, on the way to the

bathroom, he can’t make it and wets his clothes.

Evaluation?Diagnosis?Appropriate treatment?

Page 8: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Overflow

Urge Stress

Functional

Types of Incontinence

Page 9: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Work-up of Incontinence

History Physical Urinalysis Post-void Residual

Volume

Page 10: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Incontinence History

Type Do you leak urine during physical activity

such as coughing, sneezing, lifting, or exercising?

Do you get the urge to go and can’t make it without leaking?

Onset

Severity Frequency of leakage Need for absorbent products

Page 11: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Incontinence History

Lower urinary tract symptoms Urgency, frequency, nocturia,

dysuria, weak stream, straining to void, etc.

Fluid intake – volume and type

Previous treatments and effects on incontinence

Page 12: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Medical History

Medical, neurological, history

Surgical history

Prostatectomy

Review medications including OTC

Habits (caffeine, tobacco, alcohol use)

Page 13: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Physical Exam

Brief Neurologic Exam Gait Lower extremity strength Cogwheel rigidity Sphincter tone and voluntary

contraction

Rectal (and Pelvic for women)

Page 14: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Urinalysis

Bacteriuria

Pyuria

Glycosuria

Hematuria

Page 15: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Post-Void Residual Volume

Measure amount of urine left in bladder after voiding.

Ultrasound or catheter

Normal: < 50 ml

Page 16: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Patient Case 75 year old man Frequent voiding and weekly urge incontinence Work up

Hx: Diabetes for 10 years, tries to adhere to diet – drinks about 4-5 diet sodas/day. Insomnia – takes Tylenol PM. Constipation.

Physical: hard stool in vault UA: 2+ glucose (and Hgb A1C = 9.8 one month ago) PVR: 200 mL

Diagnosis? Treatment Options?

Page 17: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Contributors to UIto Treat First

Drugs and DietInfectionAtrophic UrethritisPsychological - Depression, DeliriumEndocrine - Diabetes, HypercalcemiaRestricted MobilityStool Impaction

Page 18: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Contributors to UIto Treat First

DrugsSedatives including alcoholACE inhibitors (cough)Antipsychotics (pseudoparkinsonism)Diuretics (bad timing)Alpha Blockers – worsen stress UIAnticholinergics – incomplete emptying

Page 19: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Contributors to UIto Treat First

Drugs and Diet – Caffeine & FluidsInfectionAtrophic UrethritisPsychological - Depression, DeliriumEndocrine - Diabetes, HypercalcemiaRestricted MobilityStool Impaction

Page 20: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Patient Case 75 year old man Frequent voiding and weekly urge incontinence Work up

Hx: Diabetes for 10 years, tries to adhere to diet – drinks about 4-5 diet sodas/day. Insomnia – takes Tylenol PM. Constipation.

Physical: hard stool in vault UA: 2+ glucose

(and Hgb A1C = 9.8 one month ago) PVR: 200 mL

Page 21: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Patient Case

75 year old man Frequent voiding and weekly urge

incontinence Work up

Hx: Otherwise negative Physical: unremarkable UA: normal PVR: 45 mL

Diagnosis? Treatment options?

Page 22: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

First Line Treatments Medications

Anticholinergics Oxybutynin – generic, Ditropan XL, Oxytrol

patch Tolterodine - Detrol Solifenacin - VESIcare Trospium - Sanctura Darifenacin - Enablex

Alpha blocker for BPH

Other treatments Behavioral training – try BEFORE or with drug

Page 23: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

PFM Training PFM Training and Exerciseand Exercise

PFM Training PFM Training and Exerciseand Exercise

Weight LossWeight LossWeight LossWeight Loss

Diet & Fluid Diet & Fluid ManagementManagement

Diet & Fluid Diet & Fluid ManagementManagement

Behavioral Behavioral ApproachesApproachesBehavioral Behavioral ApproachesApproaches

Behavioral Behavioral StrategiesStrategies

Behavioral Behavioral StrategiesStrategies

Bladder TrainingBladder TrainingBladder TrainingBladder Training BiofeedbackBiofeedbackBiofeedbackBiofeedback

Bladder Bladder DiariesDiaries

Bladder Bladder DiariesDiaries

Least Invasive – Use First !!

Page 24: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Behavioral Treatment: Multi-component Program

Pelvic floor muscle training

Home practice of exercisesIncrease duration of contraction/relaxation over time

Bladder Control Techniques

Self-Monitoring w/ bladder diaries

Page 25: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

When the Urge Strikes –Freeze and Squeeze

Stop and stay still

Squeeze pelvic floor muscles

Relax rest of body

Concentrate on suppressing urge

Wait until the urge subsides

Walk to bathroom at normal pace

Burgio et al. Staying Dry: A Practical Guide to Bladder Control. 1989.

Page 26: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

When to Void

WorstWorstTimeTime

WorstWorstTimeTime

BestBestTimeTime

CalmCalmPeriodPeriod

Burgio et al. Staying Dry: A Practical Guide to Bladder Control. 1989.

Page 27: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Other Behavioral Strategies

Stress Strategy

Squeeze before you sneeze (or cough or lift)

Post Void Dribbling Strategy

Squeeze after voiding

Page 28: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

RCT Comparing Behavior and Drug Therapy

197 older women with urge incontinence Randomized to 8 weeks of:

Behavioral training (biofeedback) Drug therapy (oxybutynin) Placebo control

Burgio et al, JAMA, 1998

Page 29: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Reduction of Incontinence

81%

39%

68%

0

20

40

60

80

100

Behavioral Drug Control

% R

edu

ctio

n

Page 30: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Patient Satisfaction with Treatment

78%

49%

28%

0%

10%

20%

30%

40%

50%

60%

70%

80%

90%

Completely satisfied

BehaviorDrugPlacebo

Burgio et al. JAMA. 1998; 280:1995-2000

Page 31: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Patient Case

85 year old woman Frequently leaks on the way to the bathroom Work up

Hx: Aricept for dementia Physical: Frail, walks slowly, uses a walker UA: normal PVR: 85 mL

Diagnosis? Treatment Options?

Page 32: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

The Patient with The Patient with Functional LimitationsFunctional Limitations

Avoid anticholinergic drugs in pts with dementiaFacilitate functional status

Mobility devicesPhysical therapy

Bedside commodeUrinal for menPrompted voiding – VERY effective

Page 33: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Post-Prostatectomy Incontinence

65 yo had radical prostatectomy 1 year ago Leaks when he coughs, sneezes or lifts

something heavy Wears a pad in the daytime, dry at

night No problem making it to the bathroom Diagnosis? Treatment Options?

Page 34: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Behavioral Treatment of Post-Prostatectomy

Incontinence

20 men; 55-87 years oldAverage 2 ½ years since surgery8 weeks of biofeedback-assisted behavioral training 78.3% decrease in accidents

(range of -12 – 100%)

Burgio, et.al., J Urology, 1989

Page 35: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Behavioral Training for Post-Prostatectomy Incontinence

Case Series of 27 men with persistent post-prostatectomy UI

Taught pelvic floor muscle exercises without using biofeedback

56.6% reduction in leakage

Meaglia et al. J Urol. 1990;144:674

Page 36: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Post-Prostatectomy Incontinence

65 yo considering

radical prostatectomy Continent Read that 72% of patients reported

incontinence persisting 1 year after surgery

and 40% wearing pads What can he do to help prevent

incontinence?

Stanford, et.al. JAMA, 2000

Page 37: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Pre-Prostatectomy Muscle Pre-Prostatectomy Muscle TrainingTraining

00.10.20.30.40.50.60.70.80.9

1

0 50 100 150 200Time in Days until Continent

prevention

control

(p = .032)

N=125

Burgio, Goode, et al, J Urol, 175:196; 2006

Page 38: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Reduction of Incontinence

3252

73

54

0102030405060708090

100

Pad Use Proportion DryDays

Burgio, Goode, et.al., J Urology, 2006Burgio, Goode, et.al., J Urology, 2006

p=.045p=.090

%

Page 39: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Pre-Prostatectomy Muscle Pre-Prostatectomy Muscle TrainingTraining

Median Time to Continence: Intervention Group - 3.5 months Control Group - > 6 month

Number Needed to Treat to get 1 additional man out of pads at 6 months = 5

Burgio, Goode, et al, J Urol, 175:196; 2006

Page 40: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Summary - Work-up of Incontinence

History

Physical

Urinalysis

Post-void Residual Volume

Page 41: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Summary: Contributors to Incontinence to Treat First

Drugs and DietInfectionAtrophic UrethritisPsychological - Depression, DeliriumEndocrine - Diabetes, HypercalcemiaRestricted MobilityStool Impaction

Page 42: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Urinary Incontinence Treatments

Behavioral Treatments Pelvic Floor Muscle

Exercises (Kegel)

Bladder training

Timed/Prompted voiding

Bladder Control Techniques

Biofeedback

Medications

Pessary

Pelvic Floor Electrical Stimulation

Magnetic Chair

Urethral Bulking Agents

Surgery

Page 43: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Current Studies at Bham/ATL GRECC

MOTIVE - Combined medication and behavioral therapy for overactive bladder in men (VA Rehab R&D)

ProsTech – Behavioral therapy with and without biofeedback and electrical stimulation for persistent incontinence in men after radical prostatectomy (NIH)

COMBO - Combined medication and behavioral therapy for urge incontinence in women (VA Rehab R&D)

ATLAS – Behavioral therapy or pessary or combined for stress incontinence in women (NIH)

RUBI - Botox injections for refractory urge incontinence in women (NIH)

Page 44: Kathryn L. Burgio, PhD Associate Director for GRECC Research & Patricia S. Goode, MD Associate Director for GRECC Clinical Programs Birmingham/Atlanta.

Contact Information

Patricia Goode, MD [email protected] 205-934-3249 Kathryn Burgio, PhD [email protected] 205-558-7067 Ken Shay, DDS, MS [email protected] 734-222-4325 http://vaww.sites.lrn.va.gov/vacatalog/cu_detail.asp?

id=22318